TCBIO logo

Texas Capital Bancshares (TCBIO) Company Overview

Profile

Full Name:

Texas Capital Bancshares, Inc.

Sector:

Financial Services

Industry:

Banks - Regional

Country:

United States

IPO:

March 26, 2021

Indexes:

Not included

Website:

http://www.texascapitalbank.com

Description:

Texas Capital Bancshares (TCBIO) is a financial services company based in Texas, offering a range of banking products and services, including commercial and personal banking, treasury management, and investment services. It focuses on serving businesses and individuals, emphasizing personalized customer service and community engagement.

Key Details

Price

$20.50

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$932.35 M(-13.31% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

2.30%

Annual Debt To Equity

0.46

Beta

0.38

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Oct 20, 23 Raymond James
Strong Buy
Oct 20, 23 RBC Capital
Sector Perform
Sep 27, 23 Truist Securities
Buy
Jul 21, 23 Wedbush
Neutral
Jul 21, 23 Raymond James
Strong Buy
Jun 29, 23 Truist Securities
Buy
Apr 24, 23 UBS
Sell
Apr 24, 23 Truist Securities
Buy
Apr 21, 23 Wedbush
Neutral
Apr 21, 23 Stephens & Co.
Overweight

Screeners with TCBIO included

US stocks
All stocks
Financial services sector
Stocks with low beta
Regional banks industry
NASDAQ earnings calendar
Stocks above SMA 200

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$20.50
TCBIO price is $20.50

Price All-time High

$28.65
TCBIO price is currently -28.45% below its historical high of $28.65

Price Analysts Target

-
TCBIO price consensus analysts' forecast is unknown

Price Most Recent Change

+0.49%
TCBIO price was up +0.49% on Mar 5, 2025

Price YTD Change

+5.51%
TCBIO price is up +5.51% since January 1st

Price 3-Year Change

-17.46%
TCBIO price is down -17.46% over the past 3 years

Market cap

Market Cap

-
TCBIO market capitalization value is unknown

Market Cap 3-Year Change

-
TCBIO market capitalization 3-year change is unknown

Market Cap All-time High

-
TCBIO market capitalization all-time high is unknown

Market Cap Sector Rank

-
TCBIO market capitalization is unknown

Technical

Beta

0.38
TCBIO beta is 0.38

200-day SMA

$20.46
TCBIO price is currently +0.20% above its 200-day simple moving average

14-day RSI

39.00
TCBIO 14-day relative strength index is 39.00

30-day Relative Volume

1.41
TCBIO 30-day relative volume is 1.41

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$932.35 M
TCBIO annual revenue is $932.35 million

Annual Revenue Analysts Estimate

$1.23 B
TCBIO annual revenue is currently -23.96% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-13.31%
TCBIO annual revenue is down -13.31% year-on-year

Annual Revenue Sector Rank

76.1%
TCBIO annual revenue is higher than 76.1% of companies in Financial Services sector

Profit

Annual Gross Profit

-
TCBIO annual gross profit value is unknown

Annual Gross Margin

-
TCBIO annual gross profit margin value is unknown

Annual Operating Profit

-
TCBIO annual operating income value is unknown

Annual Operating Margin

-
TCBIO annual operating profit margin value is unknown

Annual Net Income

$77.51 M
TCBIO annual net profit is $77.51 million

Annual Net Margin

-
TCBIO annual net profit margin value is unknown

EPS

Annual EPS

-
TCBIO annual earnings per share value is unknown

Annual EPS Analysts Estimate

-
TCBIO annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-
TCBIO annual earnings per share 1-year change is unknown

Annual EPS Sector Rank

-
TCBIO annual earnings per share is unknown

ROA & ROE

Annual ROA

0.25%
TCBIO annual return on assets is 0.25%

Annual ROE

2.30%
TCBIO annual return on equity is 2.30%

EBIT & EBITDA

Annual EBIT

$935.31 M
TCBIO annual earnings before interest & taxes is $935.31 million

Annual EBITDA

$989.54 M
TCBIO annual EBITDA is $989.54 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TCBIO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TCBIO price to earnings ratio is unknown

PB Ratio

PB Ratio

-
TCBIO price to book ratio value is unknown

PB Ratio Sector Rank

-
TCBIO price to book ratio is unknown

PS Ratio

PS Ratio

-
TCBIO price to sales ratio value is unknown

PS Ratio Sector Rank

-
TCBIO price to sales ratio is unknown

Enterprise value

Enterprise Value

-
TCBIO enterprise value value is unknown

Enterprise Value Sector Rank

-
TCBIO enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
TCBIO EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
TCBIO EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

-
TCBIO annual current ratio value is unknown

Annual Quick Ratio

-
TCBIO annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.46
TCBIO annual debt to equity ratio is 0.46

Annual Interest Coverage Ratio

1.13
TCBIO annual interest coverage ratio is 1.13

Risk & Stability

Piotroski F-Score

-
TCBIO piotroski f-score value is unknown

Altman Z-Score

-
TCBIO altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$30.73 B
TCBIO annual total assets is $30.73 billion

Annual Non Current Assets

-
TCBIO annual long term assets value is unknown

Annual Current Assets

-
TCBIO annual total current assets value is unknown

Annual Cash & Cash Equivalents

$3.19 B
TCBIO annual cash & cash equivalents is $3.19 billion

Equity

Annual Book Value

$3.07 B
TCBIO annual book value is $3.07 billion

Annual Working Capital

-
TCBIO annual working capital value is unknown

Liabilities

Annual Total Liabilities

$27.36 B
TCBIO annual total liabilities is $27.36 billion

Annual Total Long Term Liabilities

-
TCBIO annual total long term liabilities value is unknown

Annual Current Liabilities

-
TCBIO annual total current liabilities value is unknown

Annual Accounts Payable

$23.68 M
TCBIO annual accounts payable is $23.68 million

Debt

Annual Total Debt

$1.55 B
TCBIO annual total debt is $1.55 billion

Annual Total Debt 1-Year Change

-34.5%
TCBIO annual total debt is down -34.5% year-on-year

Annual Long Term Debt

$660.35 M
TCBIO annual long term debt is $660.35 million

Annual Short Term Debt

$885.00 M
TCBIO annual short term debt is $885.00 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

-
TCBIO annual total expenses value is unknown

Annual Operating Expenses

-
TCBIO annual total operating expenses value is unknown

Annual Cost Of Goods Sold

-
TCBIO annual cost of goods sold value is unknown

Annual SGA

$512.28 M
TCBIO annual SGA is $512.28 million

Annual D&A

$54.23 M
TCBIO annual depreciation & amortization is $54.23 million

Annual Interest Expense

$828.25 M
TCBIO annual interest expense is $828.25 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$481.12 M
TCBIO annual cash flow from operations is $481.12 million

Annual CFO 1-Year Change

+28.73%
TCBIO annual cash flow from operations is up +28.73% year-on-year

Annual CFI

-$2.48 B
TCBIO annual cash flow from investing activities is -$2.48 billion

Annual CFI 1-Year Change

-41.22%
TCBIO annual cash flow from investing activities is down -41.22% year-on-year

Annual CFF

$1.94 B
TCBIO annual cash flow from financing activities is $1.94 billion

Annual CFF 1-Year Change

+601.44%
TCBIO annual cash flow from financing activities is up +601.44% year-on-year

Free CashFlow

Annual FCF

$416.28 M
TCBIO annual free cash flow is $416.28 million

Annual FCF 1-Year Change

+16.49%
TCBIO annual free cash flow is up +16.49% year-on-year

CAPEX

Annual CAPEX

$64.84 M
TCBIO annual capital expenditures is $64.84 million

Annual CAPEX 1-Year Change

+295.83%
TCBIO annual capital expenditures is up +295.83% year-on-year

Institutional Ownership

Similar stocks

FAQ

  • What is the ticker symbol for Texas Capital Bancshares?
  • Does Texas Capital Bancshares pay dividends?
  • What sector is Texas Capital Bancshares in?
  • What industry is Texas Capital Bancshares in?
  • What country is Texas Capital Bancshares based in?
  • When did Texas Capital Bancshares go public?
  • Is Texas Capital Bancshares in the S&P 500?
  • Is Texas Capital Bancshares in the NASDAQ 100?
  • Is Texas Capital Bancshares in the Dow Jones?
  • When does Texas Capital Bancshares report earnings?

What is the ticker symbol for Texas Capital Bancshares?

The ticker symbol for Texas Capital Bancshares is NASDAQ:TCBIO

Does Texas Capital Bancshares pay dividends?

No, Texas Capital Bancshares does not pay dividends

What sector is Texas Capital Bancshares in?

Texas Capital Bancshares is in the Financial Services sector

What industry is Texas Capital Bancshares in?

Texas Capital Bancshares is in the Banks - Regional industry

What country is Texas Capital Bancshares based in?

Texas Capital Bancshares is headquartered in United States

When did Texas Capital Bancshares go public?

Texas Capital Bancshares's initial public offering (IPO) was on March 26, 2021

Is Texas Capital Bancshares in the S&P 500?

No, Texas Capital Bancshares is not included in the S&P 500 index

Is Texas Capital Bancshares in the NASDAQ 100?

No, Texas Capital Bancshares is not included in the NASDAQ 100 index

Is Texas Capital Bancshares in the Dow Jones?

No, Texas Capital Bancshares is not included in the Dow Jones index

When does Texas Capital Bancshares report earnings?

The date for Texas Capital Bancshares's next earnings report has not been announced yet